Yahoo Web Search

Search results

1. • 

     Drug targeting clear cell renal cell carcinoma shows promising approach

     Newswise· 3 days ago

     April 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...

2. • 

     Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?

     Investor's Business Daily· 1 day ago

     Patients will receive Keytruda or Keytruda plus the vaccine after bladder or kidney removal. Bladder...

3. • Cancer drug trial provides lessons for future

     Medical Xpress· 7 hours ago

     A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according ...

4. • 

     Merck (MRK) Q1 2024 Earnings Call Transcript

     Motley Fool via Yahoo Finance· 4 hours ago

     Outside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast ...

5. • Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting

     WSYR 9 Syracuse· 22 hours ago

     First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study. First-in-class ...

6. • Signs and Symptoms of Kidney Cancer

     Health via Yahoo News· 1 week ago

     In fact, kidney cancer is often found accidentally during a routine physical or imaging exam, such as an X-ray or MRI. There are three main types of kidney cancers ...

7. • 

     Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

     Technology Networks· 1 week ago

     Treatment with pembrolizumab, an immunotherapy drug, after surgery significantly prolonged overall...

8. • 

     Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales

     Zacks via Yahoo Finance· 8 hours ago

     Keytruda, the biggest product in Merck’s portfolio, generated sales of $6.95 billion in the quarter,...

9. • 

     Merck highlights progress on HIV, hypertension, cervical cancer drugs

     WFMZ Eastern Pennsylvania and Western New Jersey· 7 hours ago

     Merck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...

10. • 

      Nexavar and dosage: Strength, form, when to use, and more

      Medical News Today· 1 week ago

      Nexavar (sorafenib) is a brand-name drug that’s prescribed for liver cancer, kidney cancer, and...